$0.17 EPS Expected for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) This Quarter

Wall Street brokerages expect Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to announce earnings per share (EPS) of $0.17 for the current quarter, Zacks reports. Ten analysts have issued estimates for Allscripts Healthcare Solutions’ earnings, with the lowest EPS estimate coming in at $0.13 and the highest estimate coming in at $0.19. Allscripts Healthcare Solutions reported earnings of $0.18 per share during the same quarter last year, which indicates a negative year over year growth rate of 5.6%. The firm is scheduled to report its next earnings report on Thursday, November 7th.

According to Zacks, analysts expect that Allscripts Healthcare Solutions will report full year earnings of $0.68 per share for the current year, with EPS estimates ranging from $0.66 to $0.71. For the next financial year, analysts forecast that the company will report earnings of $0.77 per share, with EPS estimates ranging from $0.72 to $0.83. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, August 8th. The software maker reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. Allscripts Healthcare Solutions had a net margin of 9.85% and a return on equity of 6.17%. The company had revenue of $444.50 million for the quarter, compared to analysts’ expectations of $449.03 million. During the same quarter in the previous year, the firm posted $0.18 earnings per share. Allscripts Healthcare Solutions’s revenue for the quarter was up .7% on a year-over-year basis.

Several research firms recently issued reports on MDRX. Deutsche Bank began coverage on shares of Allscripts Healthcare Solutions in a report on Thursday, September 26th. They issued a “hold” rating and a $11.00 target price on the stock. TheStreet upgraded shares of Allscripts Healthcare Solutions from a “d+” rating to a “c-” rating in a report on Friday, September 20th. Evercore ISI restated a “hold” rating and issued a $11.50 target price on shares of Allscripts Healthcare Solutions in a report on Sunday, August 11th. ValuEngine upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Monday, September 30th. Finally, Jefferies Financial Group began coverage on shares of Allscripts Healthcare Solutions in a report on Friday, August 23rd. They issued a “buy” rating and a $13.00 target price on the stock. Ten investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $12.19.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Allscripts Healthcare Solutions by 2.2% in the 2nd quarter. Vanguard Group Inc. now owns 16,523,536 shares of the software maker’s stock worth $192,169,000 after acquiring an additional 363,005 shares during the last quarter. Tamarack Advisers LP raised its holdings in shares of Allscripts Healthcare Solutions by 10.6% in the 2nd quarter. Tamarack Advisers LP now owns 3,925,000 shares of the software maker’s stock worth $45,726,000 after acquiring an additional 375,000 shares during the last quarter. Neuberger Berman Group LLC raised its holdings in shares of Allscripts Healthcare Solutions by 8.3% in the 1st quarter. Neuberger Berman Group LLC now owns 3,121,749 shares of the software maker’s stock worth $29,786,000 after acquiring an additional 239,288 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Allscripts Healthcare Solutions by 9.7% in the 2nd quarter. Northern Trust Corp now owns 2,906,636 shares of the software maker’s stock worth $33,804,000 after acquiring an additional 256,892 shares during the last quarter. Finally, Paradigm Capital Management Inc. NY raised its holdings in shares of Allscripts Healthcare Solutions by 1.9% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,903,700 shares of the software maker’s stock worth $22,140,000 after acquiring an additional 35,400 shares during the last quarter.

MDRX stock traded down $0.20 during midday trading on Wednesday, hitting $10.39. The stock had a trading volume of 44,784 shares, compared to its average volume of 1,654,177. The firm has a market cap of $1.76 billion, a P/E ratio of 18.90, a price-to-earnings-growth ratio of 2.44 and a beta of 1.39. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.70. Allscripts Healthcare Solutions has a 1-year low of $8.54 and a 1-year high of $14.17. The business has a fifty day moving average price of $10.03 and a two-hundred day moving average price of $10.20.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Featured Story: Convertible Shares

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.